MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Research Information Disclosure In The PPMI Study: Development Of A Disclosure Process

    T. Tropea, J. Schulze, C. Destro, L. Heathers, B. Henry, JM. Talarico, C. Stanley, M. Mcguire Kuhl, E. Flagg, T. Foroud (Philadelphia, USA)

    Objective: The Parkinson Progression Markers Initiative (PPMI) is a multinational, longitudinal observational study that collects clinical, imaging, biologic, and genetic data from participants with or…
  • 2024 International Congress

    Rationale and Design of the Slowing Parkinson’s Early through Exercise Dosage – United Kingdom (Slow-SPEED-UK) Trial

    E. Mitchell (London, United Kingdom)

    Objective: Slow-SPEED-UK is a randomized controlled trial investigating the effects of an app-based exercise program on individuals at higher risk of Parkinson’s Disease (PD). Background:…
  • 2024 International Congress

    Clinical correlates of apathy in Parkinson´s disease

    J. Arena, L. Fiorentini, C. Obarrio, M. Merello (Buenos Aires, Argentina)

    Objective: To investigate the demographic and clinical correlates of apathy in a group of patients from a Movement Disorders clinic in Latin America. Background: Apathy…
  • 2024 International Congress

    Global Trend of Parkinson’s Disease in 38 OECD Countries from 1990-2019: An Insight from the GBD 2019.

    H. Desai, H. Chhayani, N. Brahmbhatt, J. Jobby, B. Desai, M. Lakkimsetti, P. Vemparala (Bhuj, India)

    Objective: The focus of this study was to assess the burden of PD in the organization for economic cooperation and development (OECD) region from 1990-2019.…
  • 2024 International Congress

    Comparison of Gastrointestinal Dysfunction in Early-onset and Late-onset Parkinson’s Disease

    C. Arora, N. Kamble, V. Holla, R. Mahale, R. Yadav, P. Pal (BENGALURU, India)

    Objective: To compare the gastrointestinal dysfunction in patients with early-onset Parkinson’s disease (EOPD) and late-onset Parkinson’s disease (LOPD). Background: Gastrointestinal dysfunction is one of the…
  • 2024 International Congress

    Estimating the Proportion of Parkinson’s Disease Clinical Trial Subjects Who Showed No Measurable MDS-UPDRS Motor Score Progression Over 1 Year

    M. Pang, J. Edgerton, L. Zhu, S. Belachew, D. Taylor, C. Kanzler, M. Yang, F. Nahab, C. Shen (Cambridge, USA)

    Objective: To determine what percentage of subjects with early Parkinson’s disease demonstrated no measurable worsening of MDS-UPDRS motor scores over 52 weeks in a Phase…
  • 2024 International Congress

    Patient Reported Outcomes of Using a Chaplain Service in a Huntington’s Disease Clinic

    C. Marshall, W. Aamodt, J. Klapper, P. Cinicola, N. Kleinberg, A. Lasker (Philadelphia, USA)

    Objective: To better understand and describe the impact of providing spiritual care, in the form of a chaplain service, to patients being seen in a…
  • 2024 International Congress

    Spectrum of Movement disorders, Imaging findings in SSPE and response to therapy – A prospective cohort study

    A. Elavarasi, D. Dash, M. Tripathi, R. Singh, D. Vibha, A. Garg (New Delhi, India)

    Objective: We present the clinical profile, imaging, treatment trends and outcomes of a cohort SSPE patients who presented to our Institute with movement disorders. Background:…
  • 2024 International Congress

    Reliability and Validity of the English Version of the Parkinson Anxiety Scale

    J. Lam, X. Tang, D. Meng, P. Uzelman, F. Pio, N. Ainsworth, F. Vila-Rodriguez, S. Appel-Cresswell (Vancouver, Canada)

    Objective: To evaluate the reliability and validity of the English version of the Parkinson Anxiety Scale (PAS) in patients with Parkinson’s disease (PD). Background: The…
  • 2024 International Congress

    Autonomic Dysfunction in Parkinson’s Disease Link with disease severity and other non-motor signs

    A. Mousli, R. Zouari, A. Rachdi, F. Nabli, D. Ben Mohamed, Z. Saeid, S. Ben Sassi (Ariana, Tunisia)

    Objective: Clarify the relationship between autonomic dysfunction, disease severity and NMS in PD patients. Background: Parkinson’s disease (PD) is characterized by a combination of motor…
  • « Previous Page
  • 1
  • …
  • 253
  • 254
  • 255
  • 256
  • 257
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley